Key Takeaways
- IBM revealed groundbreaking chip technology featuring 0.7nm transistor architecture, marking the first sub-1 nanometer milestone
- Shares climbed more than 6% during premarket hours following the announcement, despite trading down approximately 11% for the year
- The innovative “nanostack” approach utilizes 3D transistor stacking, achieving up to 50% performance gains or 70% improved energy efficiency compared to existing technology
- The breakthrough design integrates nearly 100 billion transistors on a chip the size of a fingernail — approximately double the transistor density of IBM’s 2nm technology from 2021
- Commercial manufacturing could launch within a five-year timeframe, though IBM has yet to identify a production partner
On Thursday, IBM revealed it has successfully engineered chip technology featuring transistors measuring 0.7 nanometers — breaking below the 1 nanometer barrier — establishing itself as the first organization to publicly achieve this technological feat.
Shares of IBM surged more than 6% in premarket activity after the disclosure. Prior to Thursday’s session, the stock had declined approximately 11% since the start of the year.
International Business Machines Corporation, IBM
The revolutionary chip employs what IBM terms a “nanostack” design framework. Instead of positioning transistors horizontally across a surface, IBM arranges them vertically in three-dimensional layers, maximizing computational capacity within an identical footprint.
IBM Research director Jay Gambetta characterized it as “reinventing how chips are built to deliver dramatically more power and energy efficiency.”
The 0.7nm technology integrates nearly 100 billion transistors on a chip measuring the size of a fingernail. This represents approximately double the transistor concentration of IBM’s 2nm chip technology, which the company introduced in 2021.
According to IBM, the advanced chip provides up to 50% enhanced performance relative to current architectures, or alternatively, up to 70% superior energy efficiency — a critical consideration as artificial intelligence applications consume increasing amounts of power.
Positioning Against Industry Rivals
Intel announced last week that its 18A manufacturing process, which creates 1.8nm chips, has progressed to risk production — the validation stage preceding full-scale commercial manufacturing. IBM’s 0.7nm revelation extends the density advantage even further.
TSMC, the globe’s leading contract semiconductor manufacturer, continues to dominate advanced chip fabrication. IBM’s strategic position appears more aligned with technology licensing rather than direct manufacturing operations.
IBM has previously granted chip technology licenses to Samsung and Japan-based Rapidus. The company has not yet disclosed a manufacturing collaborator for the 0.7nm production process.
Bridging Laboratory Innovation and Commercial Reality
IBM projects that commercial-scale manufacturing could commence within a five-year window. This extended timeline has emerged as a concern among certain investors.
Markets responded favorably initially, though the stock surrendered gains as traders evaluated the substantial gap between laboratory demonstration and actual revenue generation. IBM has provided no revised financial guidance or near-term commercialization strategy related to this technology.
The issue is clear: pioneering chip innovation requires substantial development investment and demands even greater capital for large-scale production. IBM maintains considerable debt obligations and has historically delivered moderate revenue expansion, providing limited margin for setbacks.
IBM’s free cash flow generation remains robust, affording the company financial flexibility to continue supporting this research alongside its artificial intelligence software and cloud computing divisions.
IBM indicated production could begin within five years. The company has not announced a manufacturing partner for the new technology.


